5-HYDROXYTRYPTAMINE RELEASE FROM PLATELETS BY DIFFERENT RED WINES - IMPLICATIONS FOR MIGRAINE

被引:21
|
作者
PATTICHIS, K
LOUCA, LL
JARMAN, J
SANDLER, M
GLOVER, V
机构
[1] Department of Chemical Pathology, Queen Charlotte's and Chelsea Hospital, London, W6 0XG, Goldhawk Road
来源
EUROPEAN JOURNAL OF PHARMACOLOGY-ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY SECTION | 1995年 / 292卷 / 02期
关键词
5-HT; (5-HYDROXYTRYPTAMINE; SEROTONIN); RED WINE; PLATELET; MIGRAINE; HEADACHE;
D O I
10.1016/0926-6917(95)90010-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We have confirmed our earlier finding that most red wines are able to bring about 5-hydroxytryptamine (5-HT, serotonin) release from platelets in vitro. Platelets from individual subjects manifested varying degrees of releasing ability but responded to different wines with a similar rank ordering. There was a high correlation (r = 0.87) between the effect of red wine and that of reserpine in different individuals. Some types of red wine caused a consistently higher release of 5-HT than others in all subjects; one red wine in particular resulted in negligible release. When several brands of this 'low-releasing' red wine were further examined, they all showed a lower activity than all the brands of a 'high-releasing' red wine type. This variation in releasing power was not related to intensity of red colour. Partial purification of red wine was achieved by column chromatography and showed releasing activity to be associated with a low molecular weight orange fraction. Preliminary studies, using solid phase extraction methods, showed that the active components lie mainly in a subgroup of the flavonoid fraction. If any of the adverse effects of red wine, such as headache induction, derive from this 5-HT releasing ability, then it may be possible to prepare red wines free from the chemical substances responsible.
引用
收藏
页码:173 / 177
页数:5
相关论文
共 50 条
  • [1] HANDLING OF 5-HYDROXYTRYPTAMINE BY PLATELETS IN MIGRAINE
    MACGREGOR, EA
    BIRD, N
    RIDLER, C
    WILKINSON, MIP
    HEADACHE, 1992, 32 (02): : 68 - 72
  • [2] HANDLING OF 5-HYDROXYTRYPTAMINE BY PLATELETS IN MIGRAINE
    MACGREGOR, EA
    BIRD, N
    RANSON, R
    RIDLER, C
    WILKINSON, MIP
    HEADACHE, 1992, 32 (06): : 305 - 309
  • [3] 5-HYDROXYTRYPTAMINE AND THE PATHOPHYSIOLOGY OF MIGRAINE
    HUMPHREY, PPA
    JOURNAL OF NEUROLOGY, 1991, 238 : S38 - S44
  • [4] 5-HYDROXYTRYPTAMINE AND ITS ROLE IN MIGRAINE
    LANCE, JW
    EUROPEAN NEUROLOGY, 1991, 31 (05) : 279 - 281
  • [5] 5-hydroxytryptamine and platelets: uptake and aggregation in hypoxic pulmonary hypertensive rats
    Awabdy, D
    Bryan-Lluka, LJ
    Wanstall, JC
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 459 (01) : 1 - 7
  • [6] REDUCED PLATELET PHENOLSULFOTRANSFERASE ACTIVITY TOWARDS DOPAMINE AND 5-HYDROXYTRYPTAMINE IN MIGRAINE
    JONES, AL
    ROBERTS, RC
    COLVIN, DW
    RUBIN, GL
    COUGHTRIE, MWH
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 49 (1-2) : 109 - 114
  • [7] PLATELET SUBSTANCE-P AND 5-HYDROXYTRYPTAMINE IN MIGRAINE AND TENSION-TYPE HEADACHE
    NAKANO, T
    SHIMOMURA, T
    TAKAHASHI, K
    IKAWA, S
    HEADACHE, 1993, 33 (10): : 528 - 532
  • [8] Release studies with rat brain cortical synaptosomes indicate that tramadol is a 5-hydroxytryptamine uptake blocker and not a 5-hydroxytryptamine releaser
    Gobbi, M
    Mennini, T
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 370 (01) : 23 - 26
  • [9] NAFTIDROFURYL INHIBITS THE RELEASE OF 5-HYDROXYTRYPTAMINE AND PLATELET-DERIVED GROWTH-FACTOR FROM HUMAN PLATELETS
    BARRADAS, MA
    JAGROOP, IA
    MIKHAILIDIS, DP
    CLINICA CHIMICA ACTA, 1994, 230 (02) : 157 - 167
  • [10] Localization and release of 5-hydroxytryptamine in the crayfish eyestalk
    Rodríguez-Sosa, L
    Picones, A
    Rosete, GC
    Islas, S
    Aréchiga, H
    JOURNAL OF EXPERIMENTAL BIOLOGY, 1997, 200 (23): : 3067 - 3077